Dong Kim

Dong Kim has a diverse and extensive work experience in the field of corporate development and finance. Dong started their career at Amgen in 2004, where they worked as a Senior Manager in the Finance department until 2008. Dong then joined Onyx Pharmaceuticals, an Amgen subsidiary, where they held various positions in Corporate Development and Finance from 2008 to 2011. In 2011, they became the Head of Corporate Development in Europe for Onyx Pharmaceuticals International, GmbH. After that, they worked as a Senior Director in Corporate Development for Onyx Pharmaceuticals, Inc. until 2014. Dong then joined OncoMed Pharmaceuticals as a Senior Director in Corporate Development until 2015. From 2015 to 2018, they served as the Vice President of Corporate Development at Aduro Biotech, which is now Chinook Therapeutics. Currently, they are the Vice President of Corporate Development at Mirum Pharmaceuticals since 2019.

Dong Kim received their Bachelor of Science degree in Mechanical Engineering from the University of California, Berkeley. Dong later pursued a Master of Business Administration degree at the University of Michigan's Stephen M. Ross School of Business from 2003 to 2005.